Table 1. Potential strategies for CRISPR/Cas9 interventions targeting cellular genes in cancer.
Gene Type | Family Example | Gene | Function | Approach | Gene Reference |
---|---|---|---|---|---|
Oncogene | Receptor tyrosine kinase | ErbB | Tyrosine kinase | Disrupt or mutate | 48, 58 |
Nonreceptor | src, abl, fps, yes, | Tyrosine kinase | Disrupt or mutate | 49 | |
G proteins | ras | Molecular Switch | Disrupt or mutate | 50 | |
Signaling kinase | raf | Serine/threonine kinase | Disrupt or mutate | 51 | |
Transcription regulator | myc | Transcription factor | Disrupt or mutate | 52 | |
Tumor Suppressor | Pocket protein | pRb | Cell cycle regulator | Repair | 78-80 |
Gene Regulation | p53 | Transcription | Repair | 81 | |
Signal regulation | PTEN | Protein phosphatase | Repair | 82 | |
DNA repair | BRCA1/2 | DNA repair | Repair | 83, 84 | |
DNA damage checkpoint | ATM | Serine/threonine kinase | Repair | 85 | |
Epigenetic Conrol loci | DNMTs | DNMT1 | DNA methyltransferase | Repair | 101 |
Histone modification | EZH2/ | Histone methylase demethylase | Repair | 103, 104 | |
Chemo-resistance | Efflux pumps | MDR-1 MRP | ABC transporter | Repair | 107, 108 |
Drug metabolism | GST-p | GSH conjugation | Repair | 111 | |
Cytokine P450 | Inactivation | Repair | 112 | ||
UGT1A1 | Gluconylation | Repair | 113 |